vs
Side-by-side financial comparison of HEALTHSTREAM INC (HSTM) and IRONWOOD PHARMACEUTICALS INC (IRWD). Click either name above to swap in a different company.
HEALTHSTREAM INC is the larger business by last-quarter revenue ($79.7M vs $47.7M, roughly 1.7× IRONWOOD PHARMACEUTICALS INC). On growth, HEALTHSTREAM INC posted the faster year-over-year revenue change (7.4% vs -47.3%). IRONWOOD PHARMACEUTICALS INC produced more free cash flow last quarter ($74.6M vs $13.0M). Over the past eight quarters, HEALTHSTREAM INC's revenue compounded faster (4.7% CAGR vs -20.2%).
HealthStream Inc is a leading U.S.-based provider of workforce development, compliance, and training solutions tailored for the healthcare industry. It offers cloud-based platforms covering clinical skill training, talent management, patient safety education, and regulatory adherence tools, serving over 4,000 healthcare organizations including hospitals, clinics, and long-term care facilities nationwide.
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
HSTM vs IRWD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $79.7M | $47.7M |
| Net Profit | — | $-2.3M |
| Gross Margin | — | — |
| Operating Margin | 3.0% | 14.3% |
| Net Margin | — | -4.8% |
| Revenue YoY | 7.4% | -47.3% |
| Net Profit YoY | — | -200.9% |
| EPS (diluted) | $0.09 | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $79.7M | $47.7M | ||
| Q3 25 | $76.5M | $122.1M | ||
| Q2 25 | $74.4M | $85.2M | ||
| Q1 25 | $73.5M | $41.1M | ||
| Q4 24 | $74.2M | $90.5M | ||
| Q3 24 | $73.1M | $91.6M | ||
| Q2 24 | $71.6M | $94.4M | ||
| Q1 24 | $72.8M | $74.9M |
| Q4 25 | — | $-2.3M | ||
| Q3 25 | $6.1M | $40.1M | ||
| Q2 25 | $5.4M | $23.6M | ||
| Q1 25 | $4.3M | $-37.4M | ||
| Q4 24 | — | $2.3M | ||
| Q3 24 | $5.7M | $3.6M | ||
| Q2 24 | $4.2M | $-860.0K | ||
| Q1 24 | $5.2M | $-4.2M |
| Q4 25 | 3.0% | 14.3% | ||
| Q3 25 | 9.9% | 61.8% | ||
| Q2 25 | 7.9% | 53.2% | ||
| Q1 25 | 6.0% | -70.7% | ||
| Q4 24 | 6.3% | 34.8% | ||
| Q3 24 | 8.9% | 28.0% | ||
| Q2 24 | 6.2% | 26.5% | ||
| Q1 24 | 7.8% | 14.7% |
| Q4 25 | — | -4.8% | ||
| Q3 25 | 8.0% | 32.8% | ||
| Q2 25 | 7.2% | 27.7% | ||
| Q1 25 | 5.9% | -90.9% | ||
| Q4 24 | — | 2.5% | ||
| Q3 24 | 7.8% | 4.0% | ||
| Q2 24 | 5.8% | -0.9% | ||
| Q1 24 | 7.2% | -5.6% |
| Q4 25 | $0.09 | $0.01 | ||
| Q3 25 | $0.20 | $0.23 | ||
| Q2 25 | $0.18 | $0.14 | ||
| Q1 25 | $0.14 | $-0.23 | ||
| Q4 24 | $0.16 | $0.03 | ||
| Q3 24 | $0.19 | $0.02 | ||
| Q2 24 | $0.14 | $-0.01 | ||
| Q1 24 | $0.17 | $-0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $36.2M | $215.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $354.0M | $-261.8M |
| Total Assets | $520.4M | $396.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $36.2M | $215.5M | ||
| Q3 25 | $53.5M | $140.4M | ||
| Q2 25 | $52.1M | $92.9M | ||
| Q1 25 | $77.3M | $108.5M | ||
| Q4 24 | $59.5M | $88.6M | ||
| Q3 24 | $57.5M | $88.2M | ||
| Q2 24 | $46.1M | $105.5M | ||
| Q1 24 | $52.4M | $121.5M |
| Q4 25 | — | — | ||
| Q3 25 | — | $199.5M | ||
| Q2 25 | — | $199.3M | ||
| Q1 25 | — | $199.2M | ||
| Q4 24 | — | $199.0M | ||
| Q3 24 | — | $198.8M | ||
| Q2 24 | — | $198.6M | ||
| Q1 24 | — | $398.3M |
| Q4 25 | $354.0M | $-261.8M | ||
| Q3 25 | $349.2M | $-264.2M | ||
| Q2 25 | $350.6M | $-308.2M | ||
| Q1 25 | $362.8M | $-334.1M | ||
| Q4 24 | $359.4M | $-301.3M | ||
| Q3 24 | $355.5M | $-311.3M | ||
| Q2 24 | $349.2M | $-321.7M | ||
| Q1 24 | $344.9M | $-330.5M |
| Q4 25 | $520.4M | $396.9M | ||
| Q3 25 | $499.9M | $396.1M | ||
| Q2 25 | $500.1M | $342.9M | ||
| Q1 25 | $524.0M | $327.2M | ||
| Q4 24 | $510.8M | $350.9M | ||
| Q3 24 | $502.8M | $389.5M | ||
| Q2 24 | $499.6M | $395.6M | ||
| Q1 24 | $511.6M | $438.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $13.2M | $74.6M |
| Free Cash FlowOCF − Capex | $13.0M | $74.6M |
| FCF MarginFCF / Revenue | 16.3% | 156.3% |
| Capex IntensityCapex / Revenue | 0.3% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $59.6M | $127.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $13.2M | $74.6M | ||
| Q3 25 | $18.0M | $47.6M | ||
| Q2 25 | $5.0M | $-15.1M | ||
| Q1 25 | $27.1M | $20.0M | ||
| Q4 24 | $11.2M | $15.2M | ||
| Q3 24 | $19.1M | $9.9M | ||
| Q2 24 | $6.5M | $33.5M | ||
| Q1 24 | $20.9M | $45.0M |
| Q4 25 | $13.0M | $74.6M | ||
| Q3 25 | $17.9M | $47.6M | ||
| Q2 25 | $2.7M | $-15.1M | ||
| Q1 25 | $26.0M | $19.9M | ||
| Q4 24 | $11.0M | — | ||
| Q3 24 | $18.8M | $9.9M | ||
| Q2 24 | $6.3M | $33.4M | ||
| Q1 24 | $20.2M | $44.9M |
| Q4 25 | 16.3% | 156.3% | ||
| Q3 25 | 23.4% | 39.0% | ||
| Q2 25 | 3.6% | -17.7% | ||
| Q1 25 | 35.4% | 48.4% | ||
| Q4 24 | 14.8% | — | ||
| Q3 24 | 25.8% | 10.8% | ||
| Q2 24 | 8.8% | 35.4% | ||
| Q1 24 | 27.8% | 60.0% |
| Q4 25 | 0.3% | 0.0% | ||
| Q3 25 | 0.1% | 0.0% | ||
| Q2 25 | 3.1% | 0.0% | ||
| Q1 25 | 1.4% | 0.1% | ||
| Q4 24 | 0.3% | 0.0% | ||
| Q3 24 | 0.4% | 0.0% | ||
| Q2 24 | 0.2% | 0.1% | ||
| Q1 24 | 1.0% | 0.1% |
| Q4 25 | — | — | ||
| Q3 25 | 2.96× | 1.19× | ||
| Q2 25 | 0.93× | -0.64× | ||
| Q1 25 | 6.25× | — | ||
| Q4 24 | — | 6.74× | ||
| Q3 24 | 3.34× | 2.71× | ||
| Q2 24 | 1.55× | — | ||
| Q1 24 | 4.01× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HSTM
| Subscription Services | $77.0M | 97% |
| Professional Services | $2.7M | 3% |
IRWD
Segment breakdown not available.
